| Bioactivity | ADS051 (BT051) is a selective, first-in-class, and orally active neutrophil activity modulator and a MRP2/FPR1 inhibitor. ADS051 (BT051) has the potential for neutrophil‐mediated disorders related diseases research[1]. |
| Name | ADS051 |
| Molar Mass | 3244 Da (Approximately) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Christopher K Murphy, et al. Development of ADS051, an oral, gut-restricted, small molecule neutrophil modulator for the treatment of neutrophil-mediated inflammatory diseases. FEBS Open Bio. 2023 Aug;13(8):1434-1446. |